Sponsor or institution

Clinical trials and research at Shanxi Bethune Hospital

• 14Clinical trials
• 1Country

Newest trials

All recruiting trials (14)

• Impact of CT-based 3D printed models on endotracheal intubation success in students

  This study tests whether training with CT-based 3D printed airway models helps students perform endotracheal intubation better than traditional teaching.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shaanxi · NCT07612995

• Gene patterns that predict response to selinexor for relapsed or refractory multiple myeloma

  We will test if multigene expression patterns can predict how adults with relapsed or refractory multiple myeloma respond to selinexor-based treatment.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07514052

• Epunamin plus DECP for relapsed or refractory multiple myeloma

  This will test whether adding Epunamin to a DECP chemotherapy regimen helps people with relapsed or refractory multiple myeloma have better treatment responses.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07497165

• Integrated Chinese and Western medicine telehealth for long-term diabetes care

  This project will test an online platform that combines Traditional Chinese Medicine and Western medicine to manage adults with type 2 diabetes remotely.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07265037

• Intraosseous infusion for critically ill hematology patients

  This study will test whether intraosseous (through-the-bone) needle infusions provide fast, reliable vascular access for adults 18–65 with severe hematologic conditions in the intensive care setting.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07239375

• Stepwise antibiotic and antifungal treatment for febrile neutropenia in blood cancer patients

  This treatment plan tests whether a stepwise escalation of antibiotics and antifungals can control infection and fever in adults with hematologic malignancies who develop febrile neutropenia.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07204522

• Integrated induction, consolidation, and transplant treatment for adult acute myeloid leukemia

  This program will try a combined chemotherapy-and-transplant approach that starts with one of two induction regimens (idarubicin- or daunorubicin-based with venetoclax), followed by consolidation and allogeneic stem cell transplant for adults with AML excluding M3.

  Recruiting Phase 2 Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07108530

• Combined chemotherapy with venetoclax and stem cell transplant for adults with Ph-negative ALL

  This trial will try a treatment plan that gives intensive chemotherapy including venetoclax, followed by consolidation chemotherapy and possible allogeneic stem cell transplant, for adults aged 18–60 with Philadelphia chromosome–negative acute lymphoblastic leukemia.

  Recruiting Phase 2/3 Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07059156

• Using a closed-loop system to manage diabetes in kidney transplant patients

  This study is testing a new system that combines an insulin pump and glucose monitor to see if it can help manage blood sugar levels better in people with diabetes who have had a kidney transplant.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT06962410

• Comparing blood glucose management methods in LADA patients

  This study is testing whether a new artificial pancreas system can manage blood sugar better than a traditional insulin pump with continuous monitoring for people with Latent Autoimmune Diabetes in Adults (LADA) who are in the hospital.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT06941675

• Using a hybrid closed-loop system to manage blood sugar in neurosurgery patients with diabetes

  This study is testing if a new hybrid closed-loop system can help manage blood sugar better than a traditional insulin pump for patients with type 2 diabetes who are having neurosurgery.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT06909071

• Using CD30 CAR-T therapy for treating relapsed lymphoma

  This study is testing a new treatment using modified T cells to see if it can help people with relapsed lymphoma that has the CD30 marker.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shangxi · NCT06850285

• New CAR-T therapy with IL-15 for treating blood cancers

  This study is testing a new CAR-T therapy combined with IL-15 to see if it can help people with blood cancers like leukemia and multiple myeloma.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT06783816

• Using umbilical cord blood to support stem cell transplants for treating aplastic anemia

  This study is testing if using umbilical cord blood can improve stem cell transplants for people with aplastic anemia compared to traditional donor matches.

  Recruiting Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT06650553

Quick answers

How many clinical trials run by Shanxi Bethune Hospital are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →